PD Dr. Jan Dörrie



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

CARs: Beyond T Cells and T Cell-Derived Signaling Domains. (2020) Sievers NM, Dörrie J, Schaft N Journal article, Review article Therapeutic cancer vaccination with ex vivo rna-transfected dendritic cells—an update (2020) Dörrie J, Schaft N, Schuler G, Schuler-Thurner B Journal article, Review article Generation of an oncolytic herpes simplex virus 1 expressing human MelanA (2019) Boscheinen J, Thomann S, Knipe DM, Deluca N, Schuler-Thurner B, Gross S, Dörrie J, et al. Journal article NF-κB activation triggers NK-cell stimulation by monocyte-derived dendritic cells. (2019) Bosch NC, Voll RE, Voskens CJ, Gross S, Seliger B, Schuler G, Schaft N, Dörrie J Journal article CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities-Merits and Challenges. (2019) Harrer D, Dörrie J, Schaft N Journal article, Review article Curatopes Melanoma: A Database of Predicted T-cell Epitopes from Overly Expressed Proteins in Metastatic Cutaneous Melanoma. (2019) Lischer C, Eberhardt M, Jaitly T, Schinzel C, Schaft N, Dörrie J, Schuler G, Vera González J Journal article Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance. (2019) Wiesinger M, Maerz J, Kummer M, Schuler G, Dörrie J, Schuler-Thurner B, Schaft N Journal article Vaccination with dendritic Cells for metastasized Uveal Melanoma: immunological and clinical Responses (2019) Moreira A, Gross S, Uslu U, Dörrie J, Kummer M, Schliep S, Sponagl F, et al. Conference contribution CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia (2019) Harrer DC, Schuler G, Dörrie J, Schaft N Journal article The transfection of natural killer T cells with a tumor-antigen specific chimeric antigen receptor (CAR) for melanoma immunotherapy (2019) Simon B, Wiesinger M, Maerz J, Wistuba-Hamprecht K, Weide B, Schuler-Thurner B, Schuler G, et al. Conference contribution